Prenuvo Raises $70M Series A Led By Felicis To Reimagine Preventive Healthcare
10/18/22, 12:02 PM
Location
redwood cityMoney raised
$70 million
Industry
medical
biotechnology
health care
Round Type
series a
Prenuvo, a pioneer in advanced, radiation-free whole body imaging for early detection of cancer and other diseases, today announced that it has raised $70M in Series A equity and debt funding led by Felicis, with participation from existing investors including Tony Fadell, NYT bestseller author and founder of Nest; Dr. Timothy A. Springer, Lasker award recipient; Anne Wojcicki, CEO of 23&Me; Steel Perlot, with Eric Schmidt as chairman; entrepreneur Rande Gerber; and wellness investor, supermodel, and actress, Cindy Crawford. The funding will be used to invest in the company’s artificial intelligence (AI) team, new radiology tools, custom advanced MRI builds, and national expansion.
Company Info
Location
redwood city, california, united states
Additional Info
Prenuvo makes MRI scanning for early detection of many types of cancer and many other diseases seamless and more widely accessible. Combining cutting-edge analysis technology with radiation-free and non-invasive full-body scans, Prenuvo’s patient-centric design is optimized to assess the body holistically and in under 60 minutes, compared with the several hours it would take to achieve this level of insight from conventional MRI scans.